Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. The pill, known as Paxlovid, is to be given in combination with an older antiviral drug called ritonavir.

Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill in 95 low and middle-income countries covering 53% of the world’s population.

Pfizer signs deal with U.N.-backed group to allow other manufacturers to make its experimental Covid-19 pill, a move that could make the treatment available to more than half of the world’s population.

What people are saying?

Carlos J Encarnacion If it is from Pfizer, must be good, if it is Ivermectin must be bad. Viagra was discovered by accident and the current use of sildenafil was not the intended one. Ivermectin is a parasite treatment for horses, but that is not sound judgement to dismiss it as a possible treatment.

Julie I wish they could come up with the vaccine in a tablet form for my needle phobic daughter, there must be millions of people with this phobia who need help.